Metastasis and Tumor Microenvironment: Research and Management
Session Overview
Metastasis and the dynamic ecosystem of the tumor microenvironment (TME) represent the fundamental biological frontiers of cancer research and the primary determinants of patient mortality. The lethal cascade—from local invasion and dissemination to distant dormancy and overt recurrence—is orchestrated by complex interactions between cancer cells and the immune, stromal, and vascular components of the TME. This session brings together cancer biologists, immunologists, and translational scientists to dissect these mechanisms and explore how cutting-edge research is building the foundational knowledge required for the next generation of metastasis-interceptive therapies.
Why This Session Matters Now
Recent technological revolutions in single-cell analysis, spatial omics, and sophisticated preclinical models have provided an unprecedented, high-resolution view of the metastatic process and TME heterogeneity. This has revealed why cancers evade therapy and recur, but translating these insights into clinical benefit remains the field’s paramount challenge. The exponential growth in research output underscores both the immense opportunity and the complexity of targeting a dynamic, adaptive system. This session addresses the critical need to bridge deep mechanistic discovery with the development of tractable therapeutic strategies aimed at eradicating minimal residual disease and preventing metastatic outgrowth.
Key Scientific and Clinical Themes
Tumor–Immune Microenvironment Interactions
Decoding the complex signaling networks and cellular states within the TME that dictate immune evasion, exclusion, and exhaustion, and how they vary across metastasis sites and in response to therapy.
Molecular Mechanisms of Cancer Metastasis
Examination of the cellular plasticity, intravasation, circulatory survival, extravasation, and organ-specific colonization programs that define the metastatic cascade, from initiating “seed” cells to established lesions.
Dormancy, Recurrence, and Minimal Residual Disease
Analysis of the biological mechanisms that allow disseminated tumor cells to enter a quiescent, therapy-resistant state for years or decades, and the stimuli that trigger their reawakening to form lethal macroscopic metastases.
Angiogenesis, Hypoxia, and Tumor Stroma Dynamics
Focus on the role of the non-immune stroma—including cancer-associated fibroblasts, extracellular matrix remodeling, and abnormal vasculature—in promoting invasion, metastasis, and creating protective niches for cancer cells.
Translational Models for Metastatic Cancer Research
Critical appraisal of the in vitro, in vivo, and ex vivo model systems (e.g., patient-derived organoids, genetically engineered mouse models, metastasis-on-a-chip) that best recapitulate human disease dynamics for therapeutic discovery.
Targeting the Microenvironment for Therapeutic Benefit
Discussion of emerging strategies to therapeutically re-educate or disrupt the TME, including stroma-modulating agents, vascular normalization, and therapies aimed at awakening dormant cells to sensitize them to treatment.
Nature of Research in This Field
Research in metastasis and TME biology is predominantly foundational and translational, characterized by explosive growth in descriptive, high-dimensional biology. The literature is dominated by efforts to synthesize these complex data into coherent models (reflected in the vast number of narrative reviews). True therapeutic development is in its earlier stages, with a growing pipeline of mechanistic clinical trials. The field demands integration of computational biology, advanced imaging, and sophisticated in vivo modeling.
Who Should Attend
This session is designed for:
- Basic and translational cancer biologists focused on metastasis and TME
- Tumor immunologists and stromal cell biologists
- Clinical oncologists interested in the biological underpinnings of treatment failure
- Pharmaceutical scientists involved in novel target discovery and biomarker development
- Fellows and graduate students seeking a comprehensive view of the field’s central challenges
Session Perspective
Understanding metastasis is understanding the true lethality of cancer. This session provides a platform to move from mapping the staggering complexity of the metastatic ecosystem to defining its core, targetable vulnerabilities. By connecting the molecular details of cellular crosstalk with the clinical reality of disease recurrence, the discussion aims to shift the paradigm from managing bulk disease to devising strategies for the early interception and elimination of the residual cells that ultimately cause cancer mortality.
If your research aligns with this session, we invite you to submit an abstract for consideration.
